Leslie Schover Discusses Cancer Treatments That Can Affect Sexual Function
Leslie Schover, PhD, clinical psychologist and professor of behavioral science at University of Texas at MD Anderson Cancer Center, discusses cancer treatments that can affect patients' sexual function.
Leslie Schover, PhD, clinical psychologist and professor of behavioral science at University of Texas at MD Anderson Cancer Center, discusses cancer treatments that can affect patients’ sexual function.
For men, pelvic surgeries such as radical prostatectomy, radical cystectomy, or abdominal perineal resection can damage nerves involved in directing blood flow to the genital area.
Chemotherapy poses problems for premenopausal women because they often experience hot flashes, severe vaginal dryness and pain, and end up in premature ovarian failure.
Aromatase inhibitors, which are used for treatment of breast and ovarian cancers, stop the production of estrogen and result in vaginal dryness, tightness, and pain. In one study, Schover found that about 25% of sexually active women stopped having sex in the first 2 years after taking an aromatase inhibitor.
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).
